AI assistant
Marksans Pharma Ltd. — Board/Management Information 2025
Jul 25, 2025
62142_rns_2025-07-25_a11e5aff-9d6e-4b4f-9aff-aecd2603dad1.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [47 x 46] intentionally omitted <==
==> picture [86 x 18] intentionally omitted <==
==> picture [111 x 18] intentionally omitted <==
Date : July 25, 2025
BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoi Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001. Bandra (East), Mumbai - 400051. Scrip Code: 524404 Symbol: MARKSANS
Sub: Outcome of Board Meeting
Dear Sir/Madam,
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) and other regulations, if applicable, we hereby inform the exchanges that the Board of Directors (“Board”) of the Company today i.e. July 25, 2025, has re-appointed Mr. Mark Saldanha (DIN: 00020983) as the Managing Director of the Company subject to approval of the shareholders at the forthcoming Annual General Meeting.
We request you to note the aforesaid in your records.
Thanking You,
Yours faithfully,
For Marksans Pharma Limited
Digitally signed by H PANIGRAHI DN: c=IN, o=Personal, title=5470, 2.5.4.20=b68fed9b4e54339fc79709c0767 H 3dbf0831efeaca440f7534fca8796f19bc37 a, postalCode=401107, st=Maharashtra, serialNumber=8504a87abeef17220e4e6f5 PANIGRAHI d37b003a37acd0ff57ca749f78aedfd26a26ce06c, cn=H PANIGRAHI Date: 2025.07.25 17:32:16 +05'30'
Harshavardhan Panigrahi Company Secretary
Enclosed as above
Annexure I
==> picture [5 x 74] intentionally omitted <==
==> picture [72 x 16] intentionally omitted <==
==> picture [93 x 16] intentionally omitted <==
==> picture [431 x 33] intentionally omitted <==
==> picture [47 x 46] intentionally omitted <==
==> picture [86 x 18] intentionally omitted <==
==> picture [111 x 18] intentionally omitted <==
Details pertaining to re-appointment of Mr. Mark Saldanha as Managing Director of Marksans Pharma Limited is given below:
| Sr. No | Particulars | Details |
|---|---|---|
| 1. | Name of Director | Mr. Mark Saldanha (DIN: 00020983) |
| 2. | Reason for Change viz., appointment, resignation, removal, death or otherwise |
Re-appointment as the Managing Director of the Company for a further period of 5 years with effect from 6thOctober 2025. |
| 3. | Date of Appointment & term of appointment |
Mr. Mark Saldanha (DIN: 00020983) has been appointed as Managing Director, for a term of 5 years effective from 6thOctober, 2025 subject to approval of the members of the Company and his office shall not be liable to retire byrotation. |
| 4. | Brief Profile: | He has over 24 years of experience in production, marketing and finance. He is the principal architect of the success and progress of the Company. Under his able, dynamic and manifold leadership, the Company rapidly growing to new heights of success and higher level of performance |
| 5. | Disclosure of relationships between directors |
Relative of Mrs. Sandra Saldanha |
==> picture [5 x 74] intentionally omitted <==
==> picture [72 x 16] intentionally omitted <==
==> picture [93 x 16] intentionally omitted <==
==> picture [431 x 33] intentionally omitted <==